Skip to main content
. 2011 Dec;66(12):2113–2119. doi: 10.1590/S1807-59322011001200018

Table 1.

The percentage change in the plasma TGF-β1 level.

Group BT-BL (%) AT-BL (%)
SX 11.7±5.64 -0.75±11.08 α
VC -46.7±3.68* -67.4±4.53*,#
CEE -34.8±5.92* -18.7±8.08 α

BT-BL, percentage change before treatment; AT-BL, percentage change after treatment. SX, sham-operated (vehicle normal saline, six weeks); VC, ovariectomized control (normal saline, six weeks); CEE, ovariectomized + estrogen (conjugated equine estrogen 100 µg/kg/day, six weeks); n = 10.

#

Significant difference when compared with the BT-BL within the same group (p = 0.045).

*

Significant difference when compared with the sham group (p<0.001).

α

Significant difference when compared with the AT-BL of the VC group (p = 0.001).